杨蓉西，教授，博士生导师，江苏省双创人才，江苏省特聘教授,中国抗癌协会肿瘤标志物专业委员会甲基化标志物专家委员会常务委员,中国老年学盒老年医学学会老年肿瘤分会转化医学专家委员会常务委员。2008年于德国海德堡大学获得分子细胞生物学硕士学位，2011年于德国国家癌症研究中心获得分子流行病博士学位（summa cum laude），2011-2013年在德国国家癌症研究中心（DKFZ）和德国海德堡大学医学院从事博士后工作，2013-2016年于德国国家癌症研究中心任课题组长。2016-2017年主持德国国家经济部eXist科技转化重大专项和主持欧盟EIT Health基金会HeadStart科技转化专项，并任德国海德堡大学医学院MammaScreen转化医学研究课题组独立PI。2017年12月起任南京医科大学公共卫生学院流行病学系教授。
发表SCI文章30余篇，获得国际发明专利4项。曾获得欧洲高科技转化大赛德国区选拔赛生物技术类一等奖， 欧洲高科技转化大赛欧洲区决赛生物技术类一等奖，瑞士Claudia von Schilling基金会颁发的乳腺癌研究青年杰出人才奖等国际奖项。担任PloS Genetics, International Journal of Cancer， Carcinogenesis, Breast Cancer Research，Breast Cancer Research and Treatment， Cancer letter等十几份SCI杂志的审稿专家。
研究方向：表观分子流行病学
联系方式：
电话：025-86868460
Email: rongxiyang@njmu.edu.cn
代表性成果（第一作者#，通讯作者*）:
1. Yang, Rongxi(#)(*); Stoecker, Sarah; Schott, Sarah; Heil, Joerg; Marme, Frederik; Cuk, Katarina; Chen, Bowang; Golatta, Michael; Zhou, Yan; Sutter, Christian; Wappenschmidt, Barbara; Schmutzler, Rita; Bugert, Peter; Qu, Bin; Bartram, Claus R.; Sohn, Christof; Schneeweiss, Andreas; Burwinkel, Barbara, The association between breast cancer and S100P methylation in peripheral blood by multicenter case- control studies, Carcinogenesis, 2017.3, 38(3): 312~320
2. Peng, Cike(#)(*); Chen, Hongda; Wallwiener, Markus; Modugno, Caroline; Cuk, Katarina; Madhavan, Dharanija; Trumpp, Andreas; Heil, Jorg; Marme, Frederik; Nees, Juliane; Riethdorf, Sabine; Schott, Sarah; Sohn, Christof; Pantel, Klaus; Schneeweiss, Andreas; Yang, Rongxi(*); Burwinkel, Barbara(*), Plasma S100P level as a novel prognostic marker of metastatic breast cancer, Breast Cancer Res Treat, 2016.6, 157(2): 329~338
3. Peng, Cike(#); Wallwiener, Markus; Rudolph, Anja; Cuk, Katarina; Eilber, Ursula; Celik, Muhabbet; Modugno, Caroline; Trumpp, Andreas; Heil, Joerg; Marme, Frederik; Madhavan, Dharanija; Nees, Juliane; Riethdorf, Sabine; Schott, Sarah; Sohn, Christof; Pantel, Klaus; Schneeweiss, Andreas; Chang-Claude, Jenny; Yang, Rongxi(*); Burwinkel, Barbara(*), Plasma hyaluronic acid level as a prognostic and monitoring marker of metastatic breast cancer, Int J Cancer, 2016.5.15, 138(10): 2499~2509
4. Maierthaler, Melanie(#)(*); Kriegsmann, Mark; Peng, Cike; Jauch, Sarah; Szabo, Akos; Wallwiener, Markus; Rom, Joachim; Sohn, Christof; Schneeweiss, Andreas; Sinn, Hans-Peter; Yang, Rongxi(*); Burwinkel, Barbara, S100P and HYAL2 as prognostic markers for patients with triple-negative breast cancer, Experimental and Molecular Pathology, 2015.8, 99(1): 180~187
5. Yang, Rongxi(#)(*); Pfuetze, Katrin; Zucknick, Manuela; Sutter, Christian; Wappenschmidt, Barbara; Marme, Frederik; Qu, Bin; Cuk, Katarina; Engel, Christoph; Schott, Sarah; Schneeweiss, Andreas; Brenner, Hermann; Claus, Rainer; Plass, Christoph; Bugert, Peter; Hoth, Markus; Sohn, Christof; Schmutzler, Rita; Bartram, Claus R.; Burwinkel, Barbara(*), DNA methylation array analyses identified breast cancer-associated HYAL2 methylation in peripheral blood, Int J Cancer, 2015.4.15, 136(8): 1845~1855 (Cover paper)
6. Yang, Rongxi(#)(*); Chen, Bowang; Pfuetze, Katrin; Buch, Stephan; Steinke, Verena; Holinski-Feder, Elke; Stoecker, Sarah; von schoenfels, Witigo; Becker, Thomas; Schackert, Hans K.; Royer-Pokora, Brigitte; Kloor, Matthias; Schmiegel, Wolff H.; Buettner, Reinhard; Engel, Christoph; Puertolas, Jesus Lascorz; Foersti, Asta; Kunkel, Nelli; Bugert, Peter; Schreiber, Stefan; Krawczak, Michael; Schafmayer, Clemens; Propping, Peter; Hampe, Jochen; Hemminki, Kari; Burwinkel, Barbara, Genome-wide analysis associates familial colorectal cancer with increases in copy number variations and a rare structural variation at 12p12.3, Carcinogenesis, 2014.2, 35(2): 315~323